| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8932722 | British Journal of Anaesthesia | 2014 | 10 Pages |
Abstract
Ropivacaine is a potent inhibitor of both NaV1.5 channel activity and metastatic colon cancer cell invasion, which may be beneficial during surgical colon cancer excision.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
D.T. Baptista-Hon, F.M. Robertson, G.B. Robertson, S.J. Owen, G.W. Rogers, E.L. Lydon, N.H. Lee, T.G. Hales,